TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma

Table 2

Logistic analysis of the relationship between clinicopathologic features of HCC and the expression of TMEM147.

Characteristics	Total (N)	Odds ratio (OR)	value
T stage (T2 & T3 & T4 vs. T1)	371	2.076 (1.375–3.149)	<0.001
N stage (N1 vs. N0)	258	72589629.123 (0.000–NA)	0.994
M stage (M1 vs. M0)	272	2.743 (0.346–55.834)	0.385
Pathologic stage (Stage III & Stage IV vs. Stage I & Stage II)	350	1.862 (1.147–3.056)	0.013
Histologic grade (G3 & G4 vs. G1 & G2)	369	2.616 (1.695–4.075)	<0.001
Tumor status (with tumor vs. tumor free)	355	1.381 (0.907–2.108)	0.133
Fibrosis Ishak score (3/4 & 5/6 vs. 0 & 1/2)	215	1.390 (0.810–2.395)	0.233
Residual tumor (R1 & R2 vs. R0)	345	1.640 (0.630–4.555)	0.318